EV/EBITDA
-16.48
-0.33-2.04%
Thu, 13 Mar 2025 20:05:05 GMT
Summary
- As of March 14, 2025, TARS EV/EBITDA is -16.48, with a fall of -0.33 (-2.04%) during the most recent trading day.
- Over the past year, TARS EV/EBITDA has dropped by -9.03 (-121.21%).
- TARS EV/EBITDA is now -632.44% below its all-time high of -2.25.
Performance
TARS EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
TARS EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -2.0% | +2.0% | +2.0% |
| 1 m1 month | +12.3% | -12.3% | -12.3% |
| 3 m3 months | -9.9% | -7.5% | -11.5% |
| 6 m6 months | -104.0% | +51.0% | +38.7% |
| ytdytd | +16.2% | -16.2% | -16.1% |
| 1 y1 year | -121.2% | +79.5% | +48.2% |
| 5 y5 years | - | - | - |
TARS EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -9.7% | -18.80 | +12.3% | |
| 3 m | 3-month | -14.84 | -11.1% | -20.42 | +19.3% |
| 6 m | 6-month | -7.44 | -121.5% | -20.42 | +19.3% |
| 1 y | 1-year | -5.23 | -215.1% | -20.42 | +19.3% |
| 3 y | 3-year | -2.25 | -632.4% | -20.42 | +19.3% |
| 5 y | 5-year | -2.25 | -632.4% | -126.62 | +87.0% |
| alltime | all time | -2.25 | -632.4% | -126.62 | +87.0% |
Tarsus Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -16.48(-16.2%) |
| 2024 | -19.66(+420.1%) |
| 2023 | -3.78(-34.8%) |
| Date | Value |
|---|---|
| 2022 | -5.80(-75.5%) |
| 2021 | -23.65(-5.4%) |
| 2020 | -25.00 |
FAQ
- What is Tarsus Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
- What is TARS EV/EBITDA year-to-date change?
- What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
What is Tarsus Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of TARS is -16.48
What is the all time high EV/EBITDA for Tarsus Pharmaceuticals?
Tarsus Pharmaceuticals all-time high EV/EBITDA is -2.25
What is TARS EV/EBITDA year-to-date change?
Tarsus Pharmaceuticals EV/EBITDA has changed by +3.18 (+16.17%) since the beginning of the year
What is Tarsus Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, TARS EV/EBITDA has changed by -9.03 (-121.21%)